http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0811624-A4
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 |
| filingDate | 1996-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0811624-A4 |
| abstract | Purine or triazolopurine compounds represented by general formula (I) or (II), wherein R?1 and R4¿ represent each hydrogen, halogeno, hydroxy, mercapto or amino; R2 represents alkyl or aryl; and R?3 and R5¿ represent each hydrogen, alkyl or aryl; and medicinal compositions comprising these compounds as the active ingredient in particular, xanthin oxidase inhibitors, remedies for hyperuricemia, or remedies or preventives for gout. |
| priorityDate | 1995-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.